Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunochemical study on serum proteins in systemic sclerosis

J M Husson, A Le Go, R Engler

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |May 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerations.

    The journal of nutrition, health & aging·2013
    Same author

    [Contribution of explanatory notes. Efficacy of the ICH plan for international clinical development of a new drug].

    Annales pharmaceutiques francaises·1999
    Same author

    Atheroembolism in HIV-positive individuals.

    Lancet (London, England)·1992
    Same author

    Femoropopliteal stent placement: long-term results.

    Radiology·1992
    Same author

    Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency.

    The Journal of clinical investigation·1992
    Same author

    Antiphospholipid antibodies and atherosclerosis.

    The American journal of medicine·1992

    Systemic sclerosis patients showed distinct serum protein differences. Type I scleroderma had elevated alpha 2 macroglobulin and C4 complement, while Type II showed broader protein increases but decreased transferrin.

    Area of Science:

    • Immunology
    • Rheumatology
    • Clinical Chemistry

    Background:

    • Systemic sclerosis is a complex autoimmune disease.
    • Barnett's classification categorizes patients into distinct types.
    • Serum protein analysis may reveal disease-specific biomarkers.

    Purpose of the Study:

    • To investigate serum protein profiles in systemic sclerosis patients.
    • To differentiate between systemic sclerosis types using protein analysis.
    • To identify potential biomarkers for disease classification.

    Main Methods:

    • Studied forty-one patients with systemic sclerosis.
    • Classified patients into three groups based on Barnett's criteria.
    • Performed multi-dimensional statistical analysis on eight serum proteins.

    Related Experiment Videos

    Main Results:

    • Significant differences in serum proteins were observed between controls and scleroderma types.
    • Type I scleroderma showed increased alpha 2 macroglobulin and C4 complement.
    • Type II scleroderma exhibited elevated levels of most studied proteins, with normal CO complement and decreased transferrin.

    Conclusions:

    • Serum protein patterns can distinguish between systemic sclerosis types.
    • Specific proteins like alpha 2 macroglobulin, C4 complement, and transferrin may serve as biomarkers.
    • Further research can explore the diagnostic and prognostic value of these findings.